Skip to content

Cognitive behavior therapy for adults with intellectual disabilities and substance use disorders

Pilot study of a cognitive behavior therapy for adults with mild or borderline intellectual disabilities (MBID) and substance use disorders (SUD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16797778
Enrollment
20
Registered
2018-01-03
Start date
2014-06-01
Completion date
Unknown
Last updated
2022-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participants with MBID with a history of Substance Use Disorder (SUD) who were referred to an outpatient SUD treatment facility Mental and Behavioural Disorders

Interventions

Participants and their direct caregivers were both individually informed by an information letter. Active informed consent was used in which participants can refuse to participate in the study by emai
VanDerNagel & Kiewik, 2016). The original manual (for individuals without MBID) consisted of a nine-week CBT program, in which the participants covered one topic each week. To adapt the original proto

Sponsors

Aveleijn
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Between June 2014 and September 2015 twenty-three participants with MBID with a history of SUD who were referred to an outpatient SUD treatment facility were included. Criteria for inclusion in this study were: 1. Dutch as a first language 2. Sufficient oral communication skills (i.e., fluent verbal speakers) 3. A mild to borderline intellectual disability (i.e., full scale IQ between 50 – 85 according to DSM-IV criteria measured by regular intelligence tests, or, when a regular intelligence test were absent the full scale IQ was estimated by the first responsible caregivers) 4. Older than 18 years of age Participants had no restrictions in remaining in other mental health treatment that they were currently receiving (e.g. EMDR or medication management)

Exclusion criteria

Exclusion criteria: 1. Non-Dutch speaking 2. Insufficient oral communication skills 3. A moderate or severe intellectual disability (i.e., full scale IQ below 50) or a normal intelligence according to DSM-IV criteria measured by regular intelligence tests, or, when a regular intelligence test were absent the full scale IQ was estimated by the first responsible caregivers) 4. Younger than 18 years of age 5. Serious psychiatric illnesses with a chance to decompensate

Design outcomes

Primary

MeasureTime frame
1. Feasibility of the CBT protocol in terms of acceptability and practicality: 1.1. Therapists complete an acceptability questionnaire after each session. In total therapists completed 18 questionnaires per client 1.2. Both clients and therapists complete a feasibility questionnaire 0 -2 weeks after ending the entire CBT+ protocol 2. Preliminary effectiveness of the treatment (in terms of decreased alcohol, stimulants and cannabis use), measured with the SumID-Q at baseline (0 - 2 weeks before the start of the treatment), post-treatment (0 - 2 weeks after ending the treatment) and at 3-months follow-up

Secondary

MeasureTime frame
Drop-out rate during the treatment

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026